New Gene Therapy Shows Promise for Treating Age Related Macular Degeneration

A new study reports that a new gene therapy shows promise in treating dry age-related macular degeneration. The gene therapy, ophNdi1, directly targets mitochondrial function that is malfunctioning in AMD.